THE METABOLISM OF HISTIDINE. VI. HISTIDINEMIA AND IMIDAZOLEPYRUVIC ACIDURIA.

THE METABOLISM OF HISTIDINE. VI. HISTIDINEMIA AND IMIDAZOLEPYRUVIC ACIDURIA. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

THE METABOLISM OF HISTIDINE. VI. HISTIDINEMIA AND IMIDAZOLEPYRUVIC ACIDURIA. Abstract Text:

R C BALDRIDGE,V H AUERBACH,

THE METABOLISM OF HISTIDINE. VI. HISTIDINEMIA AND IMIDAZOLEPYRUVIC ACIDURIA. Publishing Authors By Initials

RC BALDRIDGE,VH AUERBACH,

For similar fluids and secretions: body fluids: urine research abstracts see: fluids and secretions: body fluids: urine research

PUBMED ID PMID:

MEDLINE DATE:

THE METABOLISM OF HISTIDINE. VI. HISTIDINEMIA AND IMIDAZOLEPYRUVIC ACIDURIA. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: The Journal of biological chemistry

VOLUME: 239

Page Numbers: 1557-9

Journal Abbreviation: J. Biol. Chem.

ISSN: 0021-9258

DAY: 24

MONTH: May

YEAR: 1964

THE METABOLISM OF HISTIDINE. VI. HISTIDINEMIA AND IMIDAZOLEPYRUVIC ACIDURIA. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 2985121

THE METABOLISM OF HISTIDINE. VI. HISTIDINEMIA AND IMIDAZOLEPYRUVIC ACIDURIA. Keywords Mesh Terms:

KEYWORDS: Urine

MESH TERMS:

Chemical & Substance for Abstract: THE METABOLISM OF HISTIDINE. VI. HISTIDINEMIA AND IMIDAZOLEPYRUVIC ACIDURIA. Information

Substance Name: Lyases

Registry Number: EC 4.-

Grant and Affiliation Information for THE METABOLISM OF HISTIDINE. VI. HISTIDINEMIA AND IMIDAZOLEPYRUVIC ACIDURIA.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Biol Chem

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

THE METABOLISM OF HISTIDINE VI HISTIDINEMIA AND IMIDAZOLEPYRUVIC ACIDURIA Related Publications

• A molecular scheme for improved characterization of human embryonic stem cell lines.
• Acetylcholine Receptor Gating: Movement in the {alpha}-Subunit Extracellular Domain.
• Acetylcholine receptor gating at extracellular transmembrane domain interface: the "pre-m1" linker.
• Acetylcholine receptor gating at extracellular transmembrane domain interface: the cys-loop and m2 m3 linker.
• An advanced molecule-surface scattering instrument for study of vibrational energy transfer in gas-solid collisions.
• Anesthesia in endodontia.
• Chemical mutagenesis.
• Determination of homosulfanilamide hydrochloride, with observations on its absorption in dogs and man.
• Directory of organizations in America, of and for the deaf.
• Emphysema: smoking's irreversible legacy.
• Empyema as a complication of chronic pulmonary tuberculosis.
• Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer.
• How to turn the reaction coordinate into time.
• Impact of reliance on CT pulmonary angiography on diagnosis of pulmonary embolism: a Bayesian analysis.
• Microwave-driven zeolite-guest systems show athermal effects from nonequilibrium molecular dynamics.
• Nociceptin/orphanin FQ decreases serotonin efflux in the rat brain but in contrast to a kappa-opioid has no antagonistic effect on mu-opioid-induced increases in serotonin efflux.
• Operationalizing the "vulnerability" and "stress" components of the hopelessness theory of depression: a multi-wave longitudinal study.
• Outcomes of care by hospitalists, general internists, and family physicians.
• Physiology of the pulpless tooth; is the pulpless tooth a dead tooth?
• Primary motor area activation during precision-demanding versus simple finger movement.
• Production of functional transgenic mice by DNA pronuclear microinjection.
• Pyrazole inhibitors of HMG-CoA reductase: an attempt to dramatically reduce synthetic complexity through minimal analog re-design.
• Qualification of embryonal carcinoma 2102Ep as a reference for human embryonic stem cell research.
• Responses to depression in children: reconceptualizing the relation among response styles.
• THE METABOLISM OF HISTIDINE. VI. HISTIDINEMIA AND IMIDAZOLEPYRUVIC ACIDURIA.
• The action of cationic detergents on bacteria and bacterial enzymes.
• The pathology of carcinoma of the bronchus.
• The relevance and future of wilderness medicine.
• Tuberculosis in children.
• Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia.